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Cardiac resynchronization therapy (CRT) is a revolutionary
technique that is an important part of the standard of care for
refractory heart failure in patients with cardiomyopathy and
conduction delay. Because of its effect on the natural history of
cardiomyopathy in the presence of interventricular conduc-
tion delay, CRT is now routinely used in patients whose heart
failure symptoms are mild. Despite its importance as
a therapy, CRT has been plagued with a nonresponse rate in
the range of 30%.Oddly, a similar nonresponse rate was noted
with the ﬁrst description of CRT (1). The nonresponse rate to
CRT has varied little in subsequent reports, despite 2 decades
of technological innovation that have facilitated implantation
of CRT systems. Although left ventricular (LV) stimulation
in the anterior cardiac vein might produce deleterious
hemodynamic effects of CRT (2), technological enhance-
ments of CRT delivery systems likely have reduced the frac-
tion of patients stimulated at inappropriate sites. Despite this,
the apparent lack of improvement in the nonresponse rate to
CRT suggests that patient characteristics continue to limit
a universal response to CRT.
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A number of patient characteristics have been identiﬁed that
might diminish the clinical response toCRT.Arrhythmias and
suboptimal programming are important sources of a failure to
deliver effective CRT that remain common (3). Left ventric-
ular scar burden, quantiﬁed by myocardial perfusion imaging,
is a negative predictor of CRT response (4). Despite a prom-
ise of improved speciﬁcity in patient selection, mechanical
dyssynchrony, quantiﬁed by multiple echocardiographic
parameters, has proven poorly sensitive to CRT response (5).
The most obvious reason for this is that mechanical dyssyn-
chrony often involves areas of scar that do not respond to
electrical stimulation. QRS duration continues to be an
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other markers of deranged interventricular conduction such as
QRSmorphology have a potent predictive valuewith beneﬁt in
mild heart failure restricted to patients with left bundle branch
block (LBBB) but not intraventricular conduction delay
(IVCD) or right bundle branch block (7). Because CRT is an
electrical therapy, metrics of conduction delay should be more
tightly coupled to CRT response. Unfortunately, QRS duration
remains a poor discriminator to preclude nonresponse to CRT.
In the report by Ploux et al. (8) in this issue of the Journal,
the authors apply 3-dimensional electrocardiographic imaging
(ECGI), developed by Ramanathan et al. (9) to study a typical
cohort of consecutive patients referred for CRT implantation.
The ECGI provides an unprecedented 3-dimensional view of
epicardial electrical activation (10), in contrast to the inher-
ently 1-dimensional view of the standard 12-lead electrocar-
diogram. The ECGI has continued to provide new insights
into the electrical substrate of normal and deranged car-
diac electrophysiology reminiscent of the impact of atomic
absorption spectra, invented by Alan Walsh (11), on analytical
chemistry. The present report provides a number of important
new insights into CRT responsiveness of “typical” patients
with either LBBB, in 18 patients, or IVCD, in 15 patients.
The authors obtained ECGI images of all patients before
CRT implantation. The electrical substrate was characterized
by imaging with a commercially available noninvasive map-
ping system (ECVUE, CardioInsight Technologies, Inc.,
Cleveland Ohio), and 3 derived metrics of electrical dyssyn-
chrony were calculated: the total left ventricular activation
time (LVTAT); the total right ventricular activation time
(RVTAT); and the ventricular electrical uncoupling (VEU)
quantiﬁedby thedifference in themeanLVTATandRVTAT.
Among patients withLBBB, regardless of etiology, the authors
observed a very uniform pattern of epicardial activation
consistent with a prior report (12). Activation began with
a single epicardial breakthrough on the right ventricle followed
by passive activation of the LV outward from the septum,
ending with the latest activation of the basolateral LV. Acti-
vation of theLVwas delayed by linear zones of slow conduction
oriented in a base to apex direction. Patients had on average 2 of
these zones of delayed conduction. In contrast, patients with
IVCD had a much more heterogeneous pattern of epicardial
activation. Althoughmost had a single epicardial breakthrough
on the right ventricle, conduction patterns varied with fewer
lines of conduction slowing that were smaller and conforma-
tions that varied in orientation. The RVTAT was similar in all
patients, but the LVTAT andVEU parameters were longer on
average in LBBB patients compared with the IVCD patients.
The most clinically relevant aspect of this paper is the
correlation between clinical response to CRT and epicardial
activation patterns. Patients were considered “responders” to
6 months of CRT if they were alive, had not been hospitalized
for heart failure, and their New York Heart Association func-
tional class had improved by 1. In the total cohort, the authors
observed a response rate of 64%, consistent with most clinical
assessments of CRT. Among responders to CRT, 16 of 21
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2445had LBBB, with a signiﬁcantly longer LVTAT and VEU
compared with nonresponders. In the nonresponder group,
9 of 11 had IVCD, and IVCD accounted for only 5 of 21 of
the responders. The authors used their measurements that
characterized electrical dyssynchrony to derive cutoff values,
optimized by receiver-operating characteristic analysis, to test
the odds ratio for CRT response prediction. The LVTATwas
the least predictive, followed by QRS duration >145 ms and
LBBB presence; and VEU was most predictive with a cutoff
value of 50 ms, associated with an odds ratio of 42.8. All
patients with LBBB had a VEU>50 ms compared with only
3 IVCD patients, all of whom responded to CRT. This cor-
responded to a positive predictive value for VEU >50 ms of
90% and the negative predictive value of 82%. In the end,
ECGI did not enhance the ability to predict a clinical response
among patients with LBBB. However, among patients with
IVCD, the ECGI analysis predicted a clinical response in
3 of 5 patients and a clinical nonresponse in 9 of 9 IVCD
patients in the nonresponse group.
The results of Ploux et al. (8) provide 2 important conclu-
sions. First, the ECGI analysis reinforces the observation that
CRT is particularly suited to treat the electrical substrate of
LBBB patients with cardiomyopathy. Second, characteriza-
tion of electrical dyssynchrony by ECGI in patients with
IVCD has the potential to noninvasively discriminate patients
that will not respond to CRT. This prediction will have to be
tested in a larger prospective patient cohort, but the potential to
improve the cost-effectiveness ofCRT therapy is clear. Finally,
the exquisite resolution of ECGI in characterizing epicardial
activation might prove useful in optimizing CRT delivery.
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